Table 3.
Baseline characteristics in women in SOF lead ancillary study by survival/mortality status.
| Characteristic | Died N = 123 | Survived N = 410 | P value |
|---|---|---|---|
| Age (years), mean ± SD | 72 ± 5 | 70 ± 4 | 0.001 |
| Education (years), mean ± SD | 12 ± 3 | 12 ± 3 | 0.811 |
| Body mass index(kg/m2)), mean ± SD | 26 ± 5 | 27 ± 5 | 0.164 |
| Alcohol (drinks/wk), mean ± SD | 1.9 ± 5 | 1.8 ± 4 | 0.840 |
| Current smoker, n (%) | 25 (20) | 41(10) | 0.002 |
| Hypertension, n (%) | 47 (39) | 106 (26) | 0.007 |
| Diabetes, n (%) | 15 (12) | 40 (10) | 0.435 |
| Current estrogen use, n (%) | 12 (10) | 55 (13) | 0.283 |
| Walk for exercise (yes/no), n (%) | 41 (33) | 172 (42) | 0.087 |
| Total hip, bone density (g/cm2), mean ± SD | 0.71 ± 0.13 | 0.77 ± 0.13 | < 0.001 |
| All cause death, B-Pb (μg/dL) [μmol/L], mean ± SD | 5.56 ± 3 [0.27 ± 0.14] | 5.17 ± 2 [0.25 ± 0.1] | 0.093 |
| CVD death, B-Pb (μg/dL), [μmol/L], mean ± SD | 5.81 ± 3 [0.28 ± 0.14 ] | 5.19 ± 3 [0.25 ± 0.14] | 0.059 |
| CHD death, B-Pb (μg/dL), [μmol/L], mean ± SD | 5.61 ± 2 [0.27 ± 0.1] | 5.19 ± 2 [0.25 ± 0.1] | 0.373 |
| Stroke death, B-Pb (μg/dL), [μmol/L], mean ± SD | 6.33 ± 3 [0.30 ± 0.14] | 5.21 ± 2 [0.25 ± 0.1] | 0.028 |
| Cancer death, B-Pb (μg/dL), [μmol/L], mean ± SD | 5.34 ± 2 [0.26 ± 0.1] | 5.25 ± 2 [0.25 ± 0.1] | 0.812 |
| Other death, B-Pb (μg/dL), [μmol/L], mean ± SD | 5.39 ± 4 [0.26 ± 0.19] | 5.25 ± 2 [0.25 ± 0.1] | 0.745 |
*B-Pb: blood lead concentration